Delivery Order SPE2DB22D2206-SPE2DB25FKB46
- Not listed
- The Defense Logistics Agency awarded a $1.34 million delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Revlimid 10 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive process and scheduled for completion by October 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $147,872 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25.8K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $53,251.31 for Revlimid 15 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Revlimid 15 mg capsules (21-count packages) under a firm fixed-price contract with a ceiling value of $32,771.71. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 4, 2025, with fulfillment performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $52,487.80 by the Defense Logistics Agency for the supply of Revlimid 25 mg capsules (100-count units). The award, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. This contract was competitively awarded and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $52,575.49 and an ultimate completion date of September 26, 2025. This is a competitively awarded, non-set-aside delivery order issued to support federal medical procurement needs. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a ceiling value of $49,926.80 and a performance period ending on May 23, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $73,936.00 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Revlimid 10 mg capsules (quantity: 28 units). This competitive award, issued under firm fixed price terms, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation, indicating the award was made through open competition. This delivery order is...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKB46Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Revlimid 25 mg capsules (100 count) with a ceiling value of $104,975.62. This firm fixed-price delivery order, which is expected to be completed by October 15, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply needs across multiple therapeutic domains through competitive procurement processes, positioning the company as a key provider within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $105.0k | 9/23/25 |